What’s the latest on drug-resistant bacteria, the impact of sepsis, and the need for better diagnostics? Explore these resources to find out more.
March, 2018 - 3iDx received Breakthrough Device Designation from FDA. Find out More >
September, 2017 - 3iDx voted The Buzz of BIO for the 2017 BIO Investor Forum. Find out More >
July, 2017 - BioHealth Innovation: Local Startup Developing Technology for Real-Time Detection of Bacteria. Read Article >
January, 2017 - Genome Web: Startup 3iDx Raising $5M for Infrared-Based Pathogen ID Platform. Read Article >
3i Diagnostics Awarded Competitive Grant from the National Science Foundation Small Business Innovation Research Program Provides Seed Funding for R&D
3i Diagnostics has been awarded a National Science Foundation Small Business Innovation Research (SBIR) grant for $225,000 to conduct research and development work on a solution for rapid microbial identification.
3i Diagnostics has developed a revolutionary method to RAPIDLY separate and identify any pathogen from a human blood sample with no need for culturing. Our technology is designed to help save lives by dramatically reducing the amount of time it takes to diagnose a microbial infection. 3iDx technology gives doctors the chance to improve patient outcomes by prescribing the right antibiotic at the right time.
“The National Science Foundation supports small businesses with the most innovative, cutting-edge ideas that have the potential to become great commercial successes and make huge societal impacts,” said Barry Johnson, Director of the NSF’s Division of Industrial Innovation and Partnerships. “We hope that this seed funding will spark solutions to some of the most important challenges of our time across all areas of science and technology.”
“This is a milestone event for 3iDx” said CEO Jim Janicki. “The funding from the NSF will advance our timetable for the development of the Biospectrix platform. NSF understood the breakthrough potential of our technology and has provided guidance and support to the company”.
3i Diagnostics has emerged from 'stealth mode' and have presented details of our technology to the public
At the 70th American Association of Clinical Chemistry Annual Scientific Meeting and Clinical Lab Expo we were awarded the inaugural "Distinguished Abstract" Award by the History of Clinical Chemistry Division.
The award recognized our work, from among the thousand or more that were submitted, as having the potential to significantly impact clinical chemistry. The award was presented during the 2018 Annual meeting of the AACC during the History Division’s luncheon and included a presentation of the work by founder and CTO Rajesh Krishnamurthy. Independently, the poster was also selected by the Annual Meeting Organizing Committee (one of four chosen for this honor) for an Oral Presentation as part of a discussion on Emerging Biomarkers and Technologies. “This is a significant honor for 3iDx” said CEO Jim Janicki. “The AACC annual meeting showcases the world’s leading clinical laboratory technology, and we’re very happy to have been selected to present here. This is a great event for us because so many of the attendees really understand the challenges in rapid, universal microbial ID and are enthusiastic about the possibilities of Biospectrix”.
A Superbug That Resisted 26 Antibiotics
December 17, 2017
"People keep asking me, how close are we to going off the cliff," says Dr. James Johnson, professor of infectious diseases medicine at the University of Minnesota. The cliffside free fall he is talking about is the day that drug-resistant bacteria will be able to outfox the world's entire arsenal of antibiotics. Common infections would then become untreatable… Read Full Article >
We are Running Out of Effective Antibiotics Fast
August 2, 2017
Each year, superbugs -- viral bacterial infections resistant to common antibiotics -- infect more than two million Americans, killing at least 38,000. As the list of antibiotic-resistant bacteria grows, so have the extraordinary efforts to prevent the spread of infection from patient to patient… Read Full Article >
Tackling Drug-Resistant Infections Globally: Final Report and Recommendations
May 1, 2016
Following 19 months of consultation and eight interim papers, each focusing on a specific aspect of antimicrobial resistance (AMR), this report sets out the Review on Antimicrobial Resistance’s annual recommendations to tackle AMR in a global way, as commissioned by our sponsors, the UK Government and the Wellcome Trust… Read Full Report >
Latest Report from the CDC: Antibiotic Resistance Threats in the United States
This report, Antibiotic resistance threats in the United States, 2013 gives a first-ever snapshot of the burden and threats posed by the antibiotic-resistant germs having the most impact on human health. Access Report >
Are State Rules For Treating Sepsis Really Saving Lives?
May 30, 2017
Doctors can save thousands of lives a year if they act promptly to identify sepsis, an often lethal reaction to infection. Sometimes called blood poisoning, sepsis is the leading cause of death in hospitals… Read Full Article >
Hunting The Nightmare Bacteria
October 22, 2013
Has the age of antibiotics come to an end? From a young girl thrust onto life support in Arizona to an uncontrollable outbreak at one of the nation’s most prestigious hospitals, FRONTLINE investigates the alarming rise of a deadly type of bacteria that our modern antibiotics can’t stop.
PCAST Releases New Report on Combating Antibiotic Resistance
September 18, 2014
Today, the President’s Council of Advisors on Science and Technology (PCAST) released a report, Combating Antibiotic Resistance. The report was released simultaneously with a National Strategy on Combating Antibiotic Resistant Bacteria as well as with a Presidential Executive Order, emphasizing to the Nation the importance of addressing this growing challenge. Read Full Article >
Superbug: An Epidemic Begins
June 15, 2014
LESS THAN A CENTURY AGO, the age-old evolutionary relationship between humans and microbes was transformed not by a gene, but by an idea. The antibiotic revolution inaugurated the era of modern medicine, trivializing once-deadly infections and paving the way for medical breakthroughs… Read Full Article >
Antibiotic Resistance: The Last Resort
July 24, 2017
Health officials are watching in horror as bacteria become resistant to powerful carbapenem antibiotics — one of the last drugs on the shelf. As a rule, high-ranking public-health officials try to avoid apocalyptic descriptors. So it was worrying to hear Thomas Frieden and Sally Davies warn of a coming health “nightmare”... Read Article >
How Can we Stop Antibiotic Resistance?
June 18, 2017
The world is heading towards a post-antibiotic era in which common infections will once again kill. If current trends continue, sophisticated interventions, like organ transplantation, joint replacements, cancer chemotherapy, and care of pre-term infants, will become more difficult or even too dangerous to undertake… Read Article >
The Antibiotic Resistance Crisis
April 4, 2015
The rapid emergence of resistant bacteria is occurring worldwide, endangering the efficacy of antibiotics, which have transformed medicine and saved millions of lives. Many decades after the first patients were treated with antibiotics, bacterial infections have again become a threat… Read Article >
Tackling Antimicrobial Drug Resistance
May 1, 2015
Delegates at the World Health Assembly endorsed a global action plan to tackle antimicrobial resistance - including antibiotic resistance, the most urgent drug resistance trend. Antimicrobial resistance is occurring everywhere in the world, compromising our ability to treat infectious diseases, as well as undermining… Read Article >
Researchers Identify Biomarker that Predicts Death in Sepsis Patients
March 8, 2017
Duke scientists have discovered a biomarker of the runaway immune response to infection called sepsis that could improve early diagnosis, prognosis, and treatment to save lives. Sepsis is implicated in half of all hospital deaths and kills… Read Article >